• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    GeneDx Holdings Corp. - Class A Common Stock (NQ:WGS)

    64.57 -1.07 (-1.63%)
    Streaming Delayed Price Updated: 12:52 PM EDT, Jul 13, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    All News about GeneDx Holdings Corp. - Class A Common Stock

    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    News headline image
    Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced – Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP, a Leading Securities Fraud Law Firm
    From Glancy Prongay Wolke & Rotter LLP
    Via Business Wire
    News headline image
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
    One of these stocks plummeted 49% on Tuesday. 
    Via The Motley Fool
    Topics Initial Public Offering
    News headline image
    GeneDx Holdings Corp. (WGS) Shareholders Who Lost Money – Contact Law Offices of Howard G. Smith About Securities Fraud Investigation
    From Law Offices of Howard G. Smith
    Via Business Wire
    GeneDx Holdings Corp (NASDAQ:WGS) Plunges 44% After Disastrous Q1 2026 Miss ↗
    Via Chartmill
    GeneDx Holdings Corp (NASDAQ:WGS) Reports Mixed Q4 2025 Results, Stock Falls Despite Strong 2026 Outlook ↗
    Via Chartmill
    News headline image
    Securities Fraud Investigation Into GeneDx Holdings Corp. (WGS) Announced – Shareholders Who Lost Money Urged to Contact The Law Offices of Frank R. Cruz
    From Law Offices of Frank R. Cruz
    Via Business Wire
    Keep an eye on the top gainers and losers in Tuesday's session. ↗
    Via Chartmill
    News headline image
    Why GeneDX Stock Is Plummeting Today ↗
    GeneDX's latest quarterly report arrived with a lot of bad news for investors. 
    Via The Motley Fool
    Which stocks are gapping on Tuesday? ↗
    Via Chartmill
    Wondering what's happening in today's pre-market session? ↗
    Via Chartmill
    News headline image
    GeneDx (WGS) Q1 2026 Earnings Transcript ↗
    GeneDx (WGS) Q1 2026 Earnings Transcript 
    Via The Motley Fool
    Top movers in Monday's after hours session ↗
    Via Chartmill
    News headline image
    GeneDx Reports First Quarter 2026 Financial Results and Updates Full-Year Outlook
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx (WGS) Q1 2025 Earnings Call Transcript ↗
    GeneDx (WGS) Q1 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Earnings
    News headline image
    GeneDx (WGS) Q2 2025 Earnings Transcript ↗
    GeneDx (WGS) Q2 2025 Earnings Transcript 
    Via The Motley Fool
    Topics Artificial Intelligence
    News headline image
    GeneDx to Report First Quarter 2026 Financial Results on Monday, May 4, 2026
    From GeneDx
    Via Business Wire
    News headline image
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
    Three stocks that have fallen more than 23% this year were on the Ark Invest CEO's shopping radar on Tuesday. 
    Via The Motley Fool
    Topics ETFs
    News headline image
    Landmark Study Shows Average Cost Savings of $80,000 Per Child and Overall Improved Health Outcomes Following GeneDx Exome and Genome Testing
    From GeneDx
    Via Business Wire
    News headline image
    Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗
    Ark Invest's CEO kicked off the new trading week with a little shopping. 
    Via The Motley Fool
    News headline image
    GeneDx to Launch Genetic Testing Program with Zevra Therapeutics to Support Patients with Suspected Niemann-Pick Disease Type C
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx to Present 18 Abstracts at ACMG 2026, Showcasing the Scale of GeneDx Infinity™ and Real-World Genomic Leadership
    From GeneDx
    Via Business Wire
    News headline image
    Relay Therapeutics Stock Up 235% This Past Year as One Fund Lifts Bet to $110 Million ↗
    Relay Therapeutics develops precision medicines targeting oncology and genetic diseases, leveraging proprietary computational technology. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    Structure Therapeutics Stock Surges 200% This Past Year as One Fund Cuts Stake by $15.5 Million ↗
    This clinical-stage biotech develops oral therapies for chronic diseases, with a lead candidate targeting type-2 diabetes and obesity. 
    Via The Motley Fool
    Topics Regulatory Compliance
    News headline image
    What a $75 Million Exit From MDU Might Signal Amid a 24% One-Year Rally ↗
    MDU Resources Group supplies regulated utilities and construction services across the U.S., with consistent revenue and a stable dividend. 
    Via The Motley Fool
    Topics Energy
    News headline image
    GeneDx's Chief Operating Officer Sold Nearly 6,000 Shares. Is the Stock a Buy or Sell? ↗
    AI-powered health intelligence firm GeneDx Holdings reported a notable insider sale as it advances its clinical data analytics platform. 
    Via The Motley Fool
    Topics Artificial Intelligence Regulatory Compliance
    News headline image
    GeneDx to Participate in Upcoming Investor Conferences
    From GeneDx
    Via Business Wire
    News headline image
    GeneDx (WGS) Q4 2025 Earnings Call Transcript ↗
    GeneDx (WGS) Q4 2025 Earnings Call Transcript 
    Via The Motley Fool
    Topics Artificial Intelligence Earnings
    News headline image
    INSERTING and REPLACING GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026
    From GeneDx
    Via Business Wire
    News headline image
    Power Solutions Stock Up 140% as $6.36 Million Exit Follows 62% Sales Surge ↗
    Power Solutions International designs and manufactures advanced engines and power systems for industrial and transportation markets. 
    Via The Motley Fool
    Topics Energy Regulatory Compliance
    News headline image
    Freshworks Falls 60% in a Year as $7.5 Million Sale Shrinks Stake to 3.1% of This Portfolio's Assets ↗
    This SaaS firm delivers cloud-based business software worldwide, focusing on subscription-driven customer and IT service solutions. 
    Via The Motley Fool
    Topics Regulatory Compliance
    < Previous 1 2 3 4 5 6 7 8 9
    ...
    15 16 Next >
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.